RecruitingPhase 3NCT07222137
A Study of Baricitinib (LY3009104) for the Delay of Stage 3 Type 1 Diabetes in At-Risk Children and Adults
Sponsor: Eli Lilly and Company
Tallahassee, FL · +6 more sites
3 recruiting type 1 diabetes studies with a site in Tallahassee, FL.
Sponsor: Eli Lilly and Company
Tallahassee, FL · +6 more sites
Sponsor: Eli Lilly and Company
Tallahassee, FL · +4 more sites
Sponsor: Florida State University
Tallahassee, FL
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.